InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Hoppenot Herve, Chairman & CEO. Officer active across 1 companies, notably INCYTE CORP. Cumulatively, 4 disclosures have been recorded. The latest transaction was disclosed on 19 November 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
02,227 shares0
Common Stock
SEC:0001209191-21-066406·
02,227 shares0
Common Stock
SEC:0001209191-21-066406:0·
044,264 shares0
Common Stock
SEC:0001209191-21-045789·
044,264 shares0
Common Stock
SEC:0001209191-21-045789:0·
4 of 4 declarations
About Hoppenot Herve
Herve Hoppenot serves as Chairman and CEO of Incyte Corp. He leads the company in developing innovative treatments for cancer and other diseases. Incyte is a biopharmaceutical company specializing in drug research and development. Mr. Hoppenot's experience in the pharmaceutical sector enables him to guide the company's strategy and innovation.
